Underdetection of Interstitial Lung Disease in Juvenile Systemic Sclerosis

Date
2022
Author
Marrani, Edoardo
Battagliotti, Cristina
Berntson, Lillemor
Bica, Blanca
Costa-Reis, Patricia
Kallinich, Tilmann
Lehman, Thomas
Minden, Kirsten
Nielsen, Susan
Nuruzzaman, Farzana
Patwardhan, Anjali
Khubchandani, Raju
Stanevicha, Valda
Uziel, Yosef
Torok, Kathryn S.
Kasapcopur, Ozgur
Adrovic, Amra
Sztajnbok, Flavio
Terreri, Maria Teresa
Anton, Jordi
Smith, Vanessa
Katsicas, Maria
Kostik, Mikhail
Vasquez-Canizares, Natalia
Avcin, Tadej
Feldman, Brian
Janarthanan, Mahesh
Santos, Maria Jose
Sawhney, Sujata
Schonenberg-Meinema, Dieneke
Sifuentes-Giraldo, Walter-Alberto
Alexeeva, Ekaterina
Appenzeller, Simone
Eleftheriou, Despina
Foeldvari, Ivan
Klotsche, Jens
Hinrichs, Bernd
Helmus, Nicola
Metadata
Show full item record
Abstract
Objective. Utilizing data obtained from a prospective, international, juvenile systemic sclerosis (SSc) cohort, the present study was undertaken to determine if pulmonary screening with forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DLco) is sufficient to assess the presence of interstitial lung disease (ILD) in comparison to high-resolution computed tomography (HRCT) in juvenile SSc.
URI
http://hdl.handle.net/20.500.12627/181526
https://doi.org/10.1002/acr.24499
Collections